Cynthia Challener - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Cynthia Challener's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Cynthia Challener
Verified
Contributing Editor, Pharmaceutical Technology
Burlington
Beats
Technology Sports Innovation. Data ScienceArtificial Intelligence
Page3, Paid Party.
Content
By Cynthia Challener Verified| BioPharm International Verified Emerging therapies provide new approaches to the treatment of many diseases and, in some cases, the potential for real cures. However, genetic medicines, cell therapies, multispecific antibodies, and other novel modalities are highly complex and present numerous challenges to their development across formulation, manufacturing, analysis, regulatory compliance, and other activities.
By Cynthia Challener Verified| BioPharm International Verified Emerging therapies provide new approaches to the treatment of many diseases and, in some cases, the potential for real cures. However, genetic medicines, cell therapies, multispecific antibodies, and other novel modalities are highly complex and present numerous challenges to their development across formulation, manufacturing, analysis, regulatory compliance, and other activities.
Company Info
Pharmaceutical Technology
Medical Device Network is an industry information platform focused on the medical device sector. It provides news, analysis, and directories related to medical device supply chains, regulatory issues, and market trends. The platform serves as a resource for professionals in the industry, offering insights and listings of medical device manufacturers and service providers. Its revenue model likely includes advertising and lead generation through company profiles and sector reports.
London, United Kingdom
+1 646-625-7388